- Home
- REAL vs ACIU Comparison
REAL vs ACIU Comparison
Compare REAL & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | ACIU |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 221.9M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | REAL | ACIU |
|---|---|---|
| Price | $11.19 | $2.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $17.00 | $10.00 |
| AVG Volume (30 Days) | ★ 3.0M | 235.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $692,845,000.00 | N/A |
| Revenue This Year | $14.30 | $706.75 |
| Revenue Next Year | $10.15 | $321.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $5.00 | $2.03 |
| 52 Week High | $17.39 | $4.00 |
Technical Indicators
Market Signals| Indicator | REAL | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 39.61 |
| Support Level | $10.36 | $2.13 |
| Resistance Level | $13.00 | $2.66 |
| Average True Range (ATR) | 0.59 | 0.12 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 58.78 | 17.00 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.
About ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.